UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 3
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
(Print or Type Responses)
1. Name and Address of Reporting Person:
Thomas J. Tisch
667 Madison Avenue
New York, NY 10021
2. Date of Event Requiring Statement (Month/Day/Year)
3/5/99
3. I.R.S. Identification Number of Reporting Person, if an entity (voluntary):
4. Issuer Name and Ticker or Trading Symbol:
Cellegy Pharmaceuticals, Inc. (CLGY)
5. Relationship of Reporting Persons(s) to Issuer:
___ Director
___ Officer (give title below)
_X_ 10% Owner
___ Other (specify below)
6. If Amendment, Date of Original (Month/Day/Year)
7. Individual or Joint/Group Filing (Check Applicable Line)
<PAGE>
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security
Common Stock, no par value
2. Amount of Securities Beneficially Owned
578,100
3. Ownership Form: Direct (D) or Indirect (I)
I
4. Nature of Indirect Beneficial Ownership
(See explanation)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
2. Date Exercisable and Expiration Date (Month/Day/Year)
Date Exercisable
Expiration Date
3. Title and Amount of Securities Underlying Derivative Security
Title
Amount or Number of Shares
2
<PAGE>
4. Conversion or Exercise Price of Derivative Security
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
6. Nature of Indirect Beneficial Ownership
Explanation of Responses:
This Form 3 is being filed jointly by the following individuals
and entities:
1. Thomas J. Tisch;
2. Daniel R. Tisch;
3. James S. Tisch;
4. Andrew H. Tisch (Thomas J. Tisch, Daniel R. Tisch, James S.
Tisch and Andrew H. Tisch are referred to collectively as the "Messrs.
Tisch");
5. Four-Fourteen Partners, LLC, a Delaware limited liability
company ("4-14P");
6. The Thomas J. Tisch 1999 Annuity Trust I ("Thomas Tisch GRAT
I");
7. The Daniel R. Tisch 1999 Annuity Trust I ("Daniel Tisch GRAT
I");
8. The James S. Tisch 1999 Annuity Trust I ("James Tisch GRAT I");
and
9. The Andrew H. Tisch 1999 Annuity Trust I ("Andrew Tisch GRAT
I"; and collectively with Thomas Tisch GRAT I, Daniel Tisch GRAT I and
James Tisch GRAT I, the "GRATs").
Thomas J. Tisch, Andrew H. Tisch, Daniel R. Tisch, James S. Tisch,
4-14P, Andrew Tisch GRAT I, Daniel Tisch GRAT I, James Tisch GRAT I, and Thomas
Tisch GRAT I are referred to herein individually as a "Reporting Person" and
collectively as the "Reporting Persons."
3
<PAGE>
The members of 4-14P are trusts for the benefit of the offspring
of the Messrs. Tisch, partnerships the partners of which are such trusts and
partnerships the partners of which are such partnerships. The Messrs. Tisch
serve as the trustees of such trusts. Thomas J. Tisch has been appointed the
Manager of 4-14P.
Each of the GRATs is a grantor retained annuity trust in which the
grantor holds an annuity interest and in which the remainder interest was
created in favor of a trust or trusts for the grantor's offspring. Thomas J.
Tisch is the grantor and Andrew H. Tisch is the trustee of Thomas Tisch GRAT I.
Daniel R. Tisch is the grantor and James S. Tisch is the trustee of Daniel Tisch
GRAT I. James S. Tisch is the grantor and Thomas J. Tisch is the trustee of
James Tisch GRAT I. Andrew H. Tisch is the grantor and Daniel R. Tisch is the
trustee of Andrew Tisch GRAT I.
On March 2, 1999, Four Partners, a New York general partnership
("FP") purchased 592,200 shares of common stock, no par value of Cellegy
Pharmaceuticals, Inc. ("Common Stock") bringing its total ownership to 2,312,400
shares of Common Stock. On March 5, 1999, the following transfers occurred (the
"GRAT Transfers"):
1. FP distributed all of the shares of Common Stock it owned in
equal shares of 578,100 each to the four trusts that are partners of
FP;
2. Each of the four trusts that are partners of FP distributed all
of the 578,100 shares of Common Stock that it had received from FP to
the Mr. Tisch who is the beneficiary of such trust;
3. Each of the Messrs. Tisch contributed all of the 578,100 shares
of Common Stock that he had received to the GRAT for which he is the
grantor.
As a result of the GRAT Transfers, FP is no longer the beneficial
owner of any shares of Common Stock. Beneficial ownership of the shares of
Common Stock previously held by FP is herein reported by the Messrs. Tisch and
the GRATs.
None of the GRAT Transfers was a "sale" for purposes of the
Securities Act of 1933, as amended (the "Securities Act"), or the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), and collectively
represented only a change in the form of beneficial ownership of the shares of
Common Stock and not an actual change in the beneficial ownership of such shares
of Common Stock.
The filing of this statement is not an admission by any Reporting
Person that such Reporting Person and any other person or persons constitute a
"group" for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934,
as amended, or Rule 13d-5 thereunder or that any Reporting Person is the
beneficial owner of any securities owned by any other person.
4
<PAGE>
[Signatures follow all attachments]
5
<PAGE>
Attachment To Form 3 of Thomas J. Tisch
in Respect of Cellegy Pharmaceuticals, Inc. (CLGY)
Date of Event Requiring Statement: 3/5/99
This Form 3 is being filed jointly by the following individuals
and entities:
1. Thomas J. Tisch;
2. Daniel R. Tisch;
3. James S. Tisch;
4. Andrew H. Tisch (Thomas J. Tisch, Daniel R. Tisch, James S.
Tisch and Andrew H. Tisch are referred to collectively as the "Messrs.
Tisch");
5. Four-Fourteen Partners, LLC, a Delaware limited liability
company ("4-14P");
6. The Thomas J. Tisch 1999 Annuity Trust I ("Thomas Tisch GRAT
I");
7. The Daniel R. Tisch 1999 Annuity Trust I ("Daniel Tisch GRAT
I");
8. The James S. Tisch 1999 Annuity Trust I ("James Tisch GRAT I");
and
9. The Andrew H. Tisch 1999 Annuity Trust I ("Andrew Tisch GRAT
I"; and collectively with Thomas Tisch GRAT I, Daniel Tisch GRAT I and
James Tisch GRAT I, the "GRATs").
Thomas J. Tisch, Andrew H. Tisch, Daniel R. Tisch, James S. Tisch,
4-14P, Andrew Tisch GRAT I, Daniel Tisch GRAT I, James Tisch GRAT I, and Thomas
Tisch GRAT I are referred to herein individually as a "Reporting Person" and
collectively as the "Reporting Persons." Thomas J. Tisch is the designated filer
for the Reporting Persons.
Joint Filer Information
1. Name and Address of Reporting Person:
Daniel R. Tisch
c/o Mentor Partners, LP
499 Park Avenue
New York, NY 10022
6
<PAGE>
2. Date of Event Requiring Statement (Month/Day/Year)
3/5/99
3. I.R.S. Identification Number of Reporting Person, if an entity (voluntary):
4. Issuer Name and Ticker or Trading Symbol:
Cellegy Pharmaceuticals, Inc. (CLGY)
5. Relationship of Reporting Persons(s) to Issuer:
___ Director
___ Officer (give title below)
_X_ 10% Owner
___ Other (specify below)
6. If Amendment, Date of Original (Month/Day/Year)
7. Individual or Joint/Group Filing (Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security
Common Stock, no par value
2. Amount of Securities Beneficially Owned
578,100
7
<PAGE>
3. Ownership Form: Direct (D) or Indirect (I)
I
4. Nature of Indirect Beneficial Ownership
(See explanation to Form 3 of Thomas J. Tisch)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
2. Date Exercisable and Expiration Date (Month/Day/Year)
Date Exercisable
Expiration Date
3. Title and Amount of Securities Underlying Derivative Security
Title
Amount or Number of Shares
4. Conversion or Exercise Price of Derivative Security
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
6. Nature of Indirect Beneficial Ownership
[Signatures follow all attachments]
8
<PAGE>
Attachment To Form 3 of Thomas J. Tisch
in Respect of Cellegy Pharmaceuticals, Inc. (CLGY)
Date of Event Requiring Statement: 3/5/99
This Form 3 is being filed jointly by the following individuals
and entities:
1. Thomas J. Tisch;
2. Daniel R. Tisch;
3. James S. Tisch;
4. Andrew H. Tisch (Thomas J. Tisch, Daniel R. Tisch, James S.
Tisch and Andrew H. Tisch are referred to collectively as the "Messrs.
Tisch");
5. Four-Fourteen Partners, LLC, a Delaware limited liability
company ("4-14P");
6. The Thomas J. Tisch 1999 Annuity Trust I ("Thomas Tisch GRAT
I");
7. The Daniel R. Tisch 1999 Annuity Trust I ("Daniel Tisch GRAT
I");
8. The James S. Tisch 1999 Annuity Trust I ("James Tisch GRAT I");
and
9. The Andrew H. Tisch 1999 Annuity Trust I ("Andrew Tisch GRAT
I"; and collectively with Thomas Tisch GRAT I, Daniel Tisch GRAT I and
James Tisch GRAT I, the "GRATs").
Thomas J. Tisch, Andrew H. Tisch, Daniel R. Tisch, James S. Tisch,
4-14P, Andrew Tisch GRAT I, Daniel Tisch GRAT I, James Tisch GRAT I, and Thomas
Tisch GRAT I are referred to herein individually as a "Reporting Person" and
collectively as the "Reporting Persons." Thomas J. Tisch is the designated filer
for the Reporting Persons.
Joint Filer Information
1. Name and Address of Reporting Person:
James S. Tisch
667 Madison Avenue
New York, NY 10021
2. Date of Event Requiring Statement (Month/Day/Year)
3/5/99
9
<PAGE>
3. I.R.S. Identification Number of Reporting Person, if an entity (voluntary):
4. Issuer Name and Ticker or Trading Symbol:
Cellegy Pharmaceuticals, Inc. (CLGY)
5. Relationship of Reporting Persons(s) to Issuer:
___ Director
___ Officer (give title below)
_X_ 10% Owner
___ Other (specify below)
6. If Amendment, Date of Original (Month/Day/Year)
7. Individual or Joint/Group Filing (Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security
Common Stock, no par value
2. Amount of Securities Beneficially Owned
19,200
578,100
3. Ownership Form: Direct (D) or Indirect (I)
I - 19,200
I - 578,100
4. Nature of Indirect Beneficial Ownership
By virtue of his status as custodian for certain accounts of his children,
James S. Tisch has power to vote or direct the vote and dispose or direct
the disposition of the
10
<PAGE>
19,200 shares of Common Stock owned by his children. The other Reporting
Persons disclaim beneficial ownership of these shares of Common Stock.
(See also explanation to Form 3 of Thomas J. Tisch)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
2. Date Exercisable and Expiration Date (Month/Day/Year)
Date Exercisable
Expiration Date
3. Title and Amount of Securities Underlying Derivative Security
Title
Amount or Number of Shares
4. Conversion or Exercise Price of Derivative Security
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
6. Nature of Indirect Beneficial Ownership
[Signatures follow all attachments]
11
<PAGE>
Attachment To Form 3 of Thomas J. Tisch
in Respect of Cellegy Pharmaceuticals, Inc. (CLGY)
Date of Event Requiring Statement: 3/5/99
This Form 3 is being filed jointly by the following individuals
and entities:
1. Thomas J. Tisch;
2. Daniel R. Tisch;
3. James S. Tisch;
4. Andrew H. Tisch (Thomas J. Tisch, Daniel R. Tisch, James S.
Tisch and Andrew H. Tisch are referred to collectively as the "Messrs.
Tisch");
5. Four-Fourteen Partners, LLC, a Delaware limited liability
company ("4-14P");
6. The Thomas J. Tisch 1999 Annuity Trust I ("Thomas Tisch GRAT
I");
7. The Daniel R. Tisch 1999 Annuity Trust I ("Daniel Tisch GRAT
I");
8. The James S. Tisch 1999 Annuity Trust I ("James Tisch GRAT I");
and
9. The Andrew H. Tisch 1999 Annuity Trust I ("Andrew Tisch GRAT
I"; and collectively with Thomas Tisch GRAT I, Daniel Tisch GRAT I and
James Tisch GRAT I, the "GRATs").
Thomas J. Tisch, Andrew H. Tisch, Daniel R. Tisch, James S. Tisch,
4-14P, Andrew Tisch GRAT I, Daniel Tisch GRAT I, James Tisch GRAT I, and Thomas
Tisch GRAT I are referred to herein individually as a "Reporting Person" and
collectively as the "Reporting Persons." Thomas J. Tisch is the designated filer
for the Reporting Persons.
Joint Filer Information
1. Name and Address of Reporting Person:
Andrew H. Tisch
667 Madison Avenue
New York, NY 10021
2. Date of Event Requiring Statement (Month/Day/Year)
3/5/99
12
<PAGE>
3. I.R.S. Identification Number of Reporting Person, if an entity (voluntary):
4. Issuer Name and Ticker or Trading Symbol:
Cellegy Pharmaceuticals, Inc. (CLGY)
5. Relationship of Reporting Persons(s) to Issuer:
___ Director
___ Officer (give title below)
_X_ 10% Owner
___ Other (specify below)
6. If Amendment, Date of Original (Month/Day/Year)
7. Individual or Joint/Group Filing (Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security
Common Stock, no par value
2. Amount of Securities Beneficially Owned
578,100
3. Ownership Form: Direct (D) or Indirect (I)
I
4. Nature of Indirect Beneficial Ownership
(See explanation to Form 3 of Thomas J. Tisch)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
13
<PAGE>
1. Title of Derivative Security
2. Date Exercisable and Expiration Date (Month/Day/Year)
Date Exercisable
Expiration Date
3. Title and Amount of Securities Underlying Derivative Security
Title
Amount or Number of Shares
4. Conversion or Exercise Price of Derivative Security
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
6. Nature of Indirect Beneficial Ownership
[Signatures follow all attachments]
14
<PAGE>
Attachment To Form 3 of Thomas J. Tisch
in Respect of Cellegy Pharmaceuticals, Inc. (CLGY)
Date of Event Requiring Statement: 3/5/99
This Form 3 is being filed jointly by the following individuals
and entities:
1. Thomas J. Tisch;
2. Daniel R. Tisch;
3. James S. Tisch;
4. Andrew H. Tisch (Thomas J. Tisch, Daniel R. Tisch, James S.
Tisch and Andrew H. Tisch are referred to collectively as the "Messrs.
Tisch");
5. Four-Fourteen Partners, LLC, a Delaware limited liability
company ("4-14P");
6. The Thomas J. Tisch 1999 Annuity Trust I ("Thomas Tisch GRAT
I");
7. The Daniel R. Tisch 1999 Annuity Trust I ("Daniel Tisch GRAT
I");
8. The James S. Tisch 1999 Annuity Trust I ("James Tisch GRAT I");
and
9. The Andrew H. Tisch 1999 Annuity Trust I ("Andrew Tisch GRAT
I"; and collectively with Thomas Tisch GRAT I, Daniel Tisch GRAT I and
James Tisch GRAT I, the "GRATs").
Thomas J. Tisch, Andrew H. Tisch, Daniel R. Tisch, James S. Tisch,
4-14P, Andrew Tisch GRAT I, Daniel Tisch GRAT I, James Tisch GRAT I, and Thomas
Tisch GRAT I are referred to herein individually as a "Reporting Person" and
collectively as the "Reporting Persons." Thomas J. Tisch is the designated filer
for the Reporting Persons.
Joint Filer Information
1. Name and Address of Reporting Person:
Four-Fourteen Partners LLC
c/o Thomas J. Tisch
667 Madison Avenue
New York, NY 10021
2. Date of Event Requiring Statement (Month/Day/Year)
15
<PAGE>
3/5/99
3. I.R.S. Identification Number of Reporting Person, if an entity (voluntary):
4. Issuer Name and Ticker or Trading Symbol:
Cellegy Pharmaceuticals, Inc. (CLGY)
5. Relationship of Reporting Persons(s) to Issuer:
___ Director
___ Officer (give title below)
_X_ 10% Owner
___ Other (specify below)
6. If Amendment, Date of Original (Month/Day/Year)
7. Individual or Joint/Group Filing (Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security
Common Stock, no par value
2. Amount of Securities Beneficially Owned
47,700
3. Ownership Form: Direct (D) or Indirect (I)
D
4. Nature of Indirect Beneficial Ownership
16
<PAGE>
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
2. Date Exercisable and Expiration Date (Month/Day/Year)
Date Exercisable
Expiration Date
3. Title and Amount of Securities Underlying Derivative Security
Title
Amount or Number of Shares
4. Conversion or Exercise Price of Derivative Security
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
6. Nature of Indirect Beneficial Ownership
[Signatures follow all attachments]
17
<PAGE>
Attachment To Form 3 of Thomas J. Tisch
in Respect of Cellegy Pharmaceuticals, Inc. (CLGY)
Date of Event Requiring Statement: 3/5/99
This Form 3 is being filed jointly by the following individuals
and entities:
1. Thomas J. Tisch;
2. Daniel R. Tisch;
3. James S. Tisch;
4. Andrew H. Tisch (Thomas J. Tisch, Daniel R. Tisch, James S.
Tisch and Andrew H. Tisch are referred to collectively as the "Messrs.
Tisch");
5. Four-Fourteen Partners, LLC, a Delaware limited liability
company ("4-14P");
6. The Thomas J. Tisch 1999 Annuity Trust I ("Thomas Tisch GRAT
I");
7. The Daniel R. Tisch 1999 Annuity Trust I ("Daniel Tisch GRAT
I");
8. The James S. Tisch 1999 Annuity Trust I ("James Tisch GRAT I");
and
9. The Andrew H. Tisch 1999 Annuity Trust I ("Andrew Tisch GRAT
I"; and collectively with Thomas Tisch GRAT I, Daniel Tisch GRAT I and
James Tisch GRAT I, the "GRATs").
Thomas J. Tisch, Andrew H. Tisch, Daniel R. Tisch, James S. Tisch,
4-14P, Andrew Tisch GRAT I, Daniel Tisch GRAT I, James Tisch GRAT I, and Thomas
Tisch GRAT I are referred to herein individually as a "Reporting Person" and
collectively as the "Reporting Persons." Thomas J. Tisch is the designated filer
for the Reporting Persons.
Joint Filer Information
1. Name and Address of Reporting Person:
The Thomas J. Tisch 1999 Annuity Trust I
c/o Mr. Barry Bloom
665 Madison Avenue
New York, NY 10021
2. Date of Event Requiring Statement (Month/Day/Year)
18
<PAGE>
3/5/99
3. I.R.S. Identification Number of Reporting Person, if an entity (voluntary):
4. Issuer Name and Ticker or Trading Symbol:
Cellegy Pharmaceuticals, Inc. (CLGY)
5. Relationship of Reporting Persons(s) to Issuer:
___ Director
___ Officer (give title below)
_X_ 10% Owner
___ Other (specify below)
6. If Amendment, Date of Original (Month/Day/Year)
7. Individual or Joint/Group Filing (Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security
Common Stock, no par value
2. Amount of Securities Beneficially Owned
578,100
3. Ownership Form: Direct (D) or Indirect (I)
D
4. Nature of Indirect Beneficial Ownership
19
<PAGE>
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
2. Date Exercisable and Expiration Date (Month/Day/Year)
Date Exercisable
Expiration Date
3. Title and Amount of Securities Underlying Derivative Security
Title
Amount or Number of Shares
4. Conversion or Exercise Price of Derivative Security
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
6. Nature of Indirect Beneficial Ownership
[Signatures follow all attachments]
20
<PAGE>
Attachment To Form 3 of Thomas J. Tisch
in Respect of Cellegy Pharmaceuticals, Inc. (CLGY)
Date of Event Requiring Statement: 3/5/99
This Form 3 is being filed jointly by the following individuals
and entities:
1. Thomas J. Tisch;
2. Daniel R. Tisch;
3. James S. Tisch;
4. Andrew H. Tisch (Thomas J. Tisch, Daniel R. Tisch, James S.
Tisch and Andrew H. Tisch are referred to collectively as the "Messrs.
Tisch");
5. Four-Fourteen Partners, LLC, a Delaware limited liability
company ("4-14P");
6. The Thomas J. Tisch 1999 Annuity Trust I ("Thomas Tisch GRAT
I");
7. The Daniel R. Tisch 1999 Annuity Trust I ("Daniel Tisch GRAT
I");
8. The James S. Tisch 1999 Annuity Trust I ("James Tisch GRAT I");
and
9. The Andrew H. Tisch 1999 Annuity Trust I ("Andrew Tisch GRAT
I"; and collectively with Thomas Tisch GRAT I, Daniel Tisch GRAT I and
James Tisch GRAT I, the "GRATs").
Thomas J. Tisch, Andrew H. Tisch, Daniel R. Tisch, James S. Tisch,
4-14P, Andrew Tisch GRAT I, Daniel Tisch GRAT I, James Tisch GRAT I, and Thomas
Tisch GRAT I are referred to herein individually as a "Reporting Person" and
collectively as the "Reporting Persons." Thomas J. Tisch is the designated filer
for the Reporting Persons.
Joint Filer Information
1. Name and Address of Reporting Person:
The Daniel R. Tisch 1999 Annuity Trust I
c/o Mr. Barry Bloom
665 Madison Avenue
New York, NY 10021
21
<PAGE>
2. Date of Event Requiring Statement (Month/Day/Year)
3/5/99
3. I.R.S. Identification Number of Reporting Person, if an entity (voluntary):
4. Issuer Name and Ticker or Trading Symbol:
Cellegy Pharmaceuticals, Inc. (CLGY)
5. Relationship of Reporting Persons(s) to Issuer:
___ Director
___ Officer (give title below)
_X_ 10% Owner
___ Other (specify below)
6. If Amendment, Date of Original (Month/Day/Year)
7. Individual or Joint/Group Filing (Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security
Common Stock, no par value
2. Amount of Securities Beneficially Owned
578,100
3. Ownership Form: Direct (D) or Indirect (I)
D
4. Nature of Indirect Beneficial Ownership
22
<PAGE>
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
2. Date Exercisable and Expiration Date (Month/Day/Year)
Date Exercisable
Expiration Date
3. Title and Amount of Securities Underlying Derivative Security
Title
Amount or Number of Shares
4. Conversion or Exercise Price of Derivative Security
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
6. Nature of Indirect Beneficial Ownership
[Signatures follow all attachments]
23
<PAGE>
Attachment To Form 3 of Thomas J. Tisch
in Respect of Cellegy Pharmaceuticals, Inc. (CLGY)
Date of Event Requiring Statement: 3/5/99
This Form 3 is being filed jointly by the following individuals
and entities:
1. Thomas J. Tisch;
2. Daniel R. Tisch;
3. James S. Tisch;
4. Andrew H. Tisch (Thomas J. Tisch, Daniel R. Tisch, James S.
Tisch and Andrew H. Tisch are referred to collectively as the "Messrs.
Tisch");
5. Four-Fourteen Partners, LLC, a Delaware limited liability
company ("4-14P");
6. The Thomas J. Tisch 1999 Annuity Trust I ("Thomas Tisch GRAT
I");
7. The Daniel R. Tisch 1999 Annuity Trust I ("Daniel Tisch GRAT
I");
8. The James S. Tisch 1999 Annuity Trust I ("James Tisch GRAT I");
and
9. The Andrew H. Tisch 1999 Annuity Trust I ("Andrew Tisch GRAT
I"; and collectively with Thomas Tisch GRAT I, Daniel Tisch GRAT I and
James Tisch GRAT I, the "GRATs").
Thomas J. Tisch, Andrew H. Tisch, Daniel R. Tisch, James S. Tisch,
4-14P, Andrew Tisch GRAT I, Daniel Tisch GRAT I, James Tisch GRAT I, and Thomas
Tisch GRAT I are referred to herein individually as a "Reporting Person" and
collectively as the "Reporting Persons." Thomas J. Tisch is the designated filer
for the Reporting Persons.
Joint Filer Information
1. Name and Address of Reporting Person:
The James S. Tisch 1999 Annuity Trust I
c/o Thomas J. Tisch
665 Madison Avenue
New York, NY 10021
24
<PAGE>
2. Date of Event Requiring Statement (Month/Day/Year)
3/5/99
3. I.R.S. Identification Number of Reporting Person, if an entity (voluntary):
4. Issuer Name and Ticker or Trading Symbol:
Cellegy Pharmaceuticals, Inc. (CLGY)
5. Relationship of Reporting Persons(s) to Issuer:
___ Director
___ Officer (give title below)
_X_ 10% Owner
___ Other (specify below)
6. If Amendment, Date of Original (Month/Day/Year)
7. Individual or Joint/Group Filing (Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security
Common Stock, no par value
2. Amount of Securities Beneficially Owned
578,100
3. Ownership Form: Direct (D) or Indirect (I)
D
4. Nature of Indirect Beneficial Ownership
25
<PAGE>
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
2. Date Exercisable and Expiration Date (Month/Day/Year)
Date Exercisable
Expiration Date
3. Title and Amount of Securities Underlying Derivative Security
Title
Amount or Number of Shares
4. Conversion or Exercise Price of Derivative Security
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
6. Nature of Indirect Beneficial Ownership
[Signatures follow all attachments]
26
<PAGE>
Attachment To Form 3 of Thomas J. Tisch
in Respect of Cellegy Pharmaceuticals, Inc. (CLGY)
Date of Event Requiring Statement: 3/5/99
This Form 3 is being filed jointly by the following individuals
and entities:
1. Thomas J. Tisch;
2. Daniel R. Tisch;
3. James S. Tisch;
4. Andrew H. Tisch (Thomas J. Tisch, Daniel R. Tisch, James S.
Tisch and Andrew H. Tisch are referred to collectively as the "Messrs.
Tisch");
5. Four-Fourteen Partners, LLC, a Delaware limited liability
company ("4-14P");
6. The Thomas J. Tisch 1999 Annuity Trust I ("Thomas Tisch GRAT
I");
7. The Daniel R. Tisch 1999 Annuity Trust I ("Daniel Tisch GRAT
I");
8. The James S. Tisch 1999 Annuity Trust I ("James Tisch GRAT I");
and
9. The Andrew H. Tisch 1999 Annuity Trust I ("Andrew Tisch GRAT
I"; and collectively with Thomas Tisch GRAT I, Daniel Tisch GRAT I and
James Tisch GRAT I, the "GRATs").
Thomas J. Tisch, Andrew H. Tisch, Daniel R. Tisch, James S. Tisch,
4-14P, Andrew Tisch GRAT I, Daniel Tisch GRAT I, James Tisch GRAT I, and Thomas
Tisch GRAT I are referred to herein individually as a "Reporting Person" and
collectively as the "Reporting Persons." Thomas J. Tisch is the designated filer
for the Reporting Persons.
Joint Filer Information
1. Name and Address of Reporting Person:
The Andrew H. Tisch 1999 Annuity Trust I
c/o Mr. Barry Bloom
665 Madison Avenue
New York, NY 10021
27
<PAGE>
2. Date of Event Requiring Statement (Month/Day/Year)
3/5/99
3. I.R.S. Identification Number of Reporting Person, if an entity (voluntary):
4. Issuer Name and Ticker or Trading Symbol:
Cellegy Pharmaceuticals, Inc. (CLGY)
5. Relationship of Reporting Persons(s) to Issuer:
___ Director
___ Officer (give title below)
_X_ 10% Owner
___ Other (specify below)
6. If Amendment, Date of Original (Month/Day/Year)
7. Individual or Joint/Group Filing (Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security
Common Stock, no par value
2. Amount of Securities Beneficially Owned
578,100
3. Ownership Form: Direct (D) or Indirect (I)
D
4. Nature of Indirect Beneficial Ownership
28
<PAGE>
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
2. Date Exercisable and Expiration Date (Month/Day/Year)
Date Exercisable
Expiration Date
3. Title and Amount of Securities Underlying Derivative Security
Title
Amount or Number of Shares
4. Conversion or Exercise Price of Derivative Security
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
6. Nature of Indirect Beneficial Ownership
[Signatures follow all attachments]
29
<PAGE>
SIGNATURE
Witness, the signatures of the undersigned this 15th day of
March, 1999.
FOUR-FOURTEEN PARTNERS, LLC
By /s/ Thomas J. Tisch
-------------------------------------
Thomas J. Tisch, Manager
/s/ Andrew H. Tisch
---------------------------------------
Andrew H. Tisch
/s/ Daniel R. Tisch
---------------------------------------
Daniel R. Tisch
/s/ James S. Tisch
---------------------------------------
James S. Tisch
/s/ Thomas J. Tisch
---------------------------------------
Thomas J. Tisch
THE ANDREW H. TISCH 1999 ANNUITY TRUST I
By /s/ Daniel R. Tisch
-------------------------------------
Daniel R. Tisch, Trustee
THE DANIEL R. TISCH 1999 ANNUITY TRUST I
By /s/ James S. Tisch
-------------------------------------
James S. Tisch, Trustee
30
<PAGE>
THE JAMES S. TISCH 1999 ANNUITY TRUST I
By /s/ Thomas J. Tisch
-------------------------------------
Thomas J. Tisch, Trustee
THE THOMAS J. TISCH 1999 ANNUITY TRUST I
By /s/ Andrew H. Tisch
-------------------------------------
Andrew H. Tisch, Trustee
31
